pharma news today obesity drugs glp-1 Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine WHO GLP-1 Treatments: WHO Endorses
Description
Vadher K, Patel H, Mody R et al (2022) Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: an adjusted indirect treatment comparison
Accordingly, GLP-1 agents are not currently recommended for colorectal cancer prevention in clinical guidelines
Skip the missed dose and resume your normal schedule the next daynever double up or adjust timing without guidance
This shift reflects a more mature interpretation of the evidence: the risk is not uniform across all GLP-1 users
W., Sattar, N
